Table 2 Clinical and treatment characteristics
Total (N = 41) | |
|---|---|
Time since schizophrenia diagnosis (years) | |
n | 41 |
Mean (SD) | 11.8 (12.26) |
Median | 6.5 |
Q1; Q3 | 0.8; 20.4 |
Range | 0; 39 |
Reason to initiate LUR treatment, n (%) | |
First choice treatment | 5 (12.20) |
Previous drugs adherence problems | 12 (29.27) |
Previous drugs lack of efficacy | 15 (36.59) |
Previous drugs tolerability problems | 6 (14.63) |
Other | 3 (7.32) |
Health setting at LUR initiation, n (%) | |
Hospital | 22 (53.66) |
Outpatient visit | 19 (46.34) |
CGI-S measurement at lurasidone initiation, n (%) | |
Borderline mentally ill | 2 (4.88) |
Mildly ill | 1 (2.44) |
Moderately ill | 8 (19.51) |
Markedly ill | 7 (17.07) |
Severely ill | 12 (29.27) |
Missing | 11 (26.83) |